1 results match your criteria: "University La Sapienza and Parco Scientifico Biomedico di Roma[Affiliation]"

In recent years a strong effort has been devoted to the search for new, safe and efficient gene therapy vectors. Phage lambda is a promising backbone for the development of new vectors: its genome can host large inserts, DNA is protected from degradation by the capsid and the ligand-exposed D and V proteins can be extensively modified. Current phage-based vectors are inefficient and/or receptor-independent transducers.

View Article and Find Full Text PDF